July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
An unusual presentation of choroideremia with macular dystrophy associated with early visual acuity loss
Author Affiliations & Notes
  • Georgios Kontos
    Oxford Eye Hospital, John Radcliffe Hospital, Oxford, ENGLAND, United Kingdom
  • Jennifer Kwan
    Oxford Eye Hospital, John Radcliffe Hospital, Oxford, ENGLAND, United Kingdom
  • Robert E MacLaren
    Oxford Eye Hospital, John Radcliffe Hospital, Oxford, ENGLAND, United Kingdom
    Nuffield Laboratory of Ophthalmology, Oxford University, Oxford, United Kingdom
  • Susan Downes
    Oxford Eye Hospital, John Radcliffe Hospital, Oxford, ENGLAND, United Kingdom
    Nuffield Laboratory of Ophthalmology, Oxford University, Oxford, United Kingdom
  • Footnotes
    Commercial Relationships   Georgios Kontos, None; Jennifer Kwan, None; Robert MacLaren, Choroideremia Research Foundation (F), Euretina (S), Nightstar Therapeutics Inc (I), Nightstar Therapeutics Inc (C), Nightstar Therapeutics Inc (E), Nightstar Therapeutics Inc (P), Nightstar Therapeutics Inc (F), Spark Therapeutics (C), University of Oxford (E), University of Oxford (P); Susan Downes, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 5387. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Georgios Kontos, Jennifer Kwan, Robert E MacLaren, Susan Downes; An unusual presentation of choroideremia with macular dystrophy associated with early visual acuity loss. Invest. Ophthalmol. Vis. Sci. 2018;59(9):5387.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Choroideremia is an X-linked recessive retinal degeneration caused by mutations in the CHM gene that encodes Rab escort protein-1 (REP1). Typically, patients present with childhood onset nyctalopia, followed by progressive narrowing of the peripheral visual fields. Central retina, and hence good visual acuity is typically well-preserved until the fifth decade of life. Here we describe an atypical phenotype characterized by profound early central visual loss in a 19-year-old Chinese male, associated with a novel predicted null mutation.

Methods : Ophthalmic history, examination, and retinal investigations were undertaken. The entire coding region (exons 1 to 15) including the splice donor and acceptor sites of CHM. were screened.

Results : The patient reported early onset night blindness, significantly reduced central vision as well as bilateral visual field loss. Fundoscopy showed central macular atrophy as well as typical features of choroideremia, with centripetal confluent areas of atrophy in the postequatorial, peripapillary and parapapillary regions. A frameshift mutation c.282delT in exon 4 of CHM was identified and segregation was demonstrated in the family; both his mother and sister were carriers of the same mutation.

Conclusions : We present an unusual macular dystrophy-like presentation of CHM in a young man. He also has a novel c.282delT in exon 4 of CHM which has not previously been reported in patients with choroideremia, but is predicted to be a null mutation. It is likely that other genetic factors may influence the unusual disease course in this case. Choroideremia should be a considered diagnosis in patients with X-linked macular dystrophy.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×